148 related articles for article (PubMed ID: 31419467)
1. Disease-modifying effects of a novel T-type calcium channel antagonist, Z944, in a model of temporal lobe epilepsy.
Casillas-Espinosa PM; Shultz SR; Braine EL; Jones NC; Snutch TP; Powell KL; O'Brien TJ
Prog Neurobiol; 2019 Nov; 182():101677. PubMed ID: 31419467
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy.
Casillas-Espinosa PM; Anderson A; Harutyunyan A; Li C; Lee J; Braine EL; Brady RD; Sun M; Huang C; Barlow CK; Shah AD; Schittenhelm RB; Mychasiuk R; Jones NC; Shultz SR; O'Brien TJ
Elife; 2023 Mar; 12():. PubMed ID: 36892461
[TBL] [Abstract][Full Text] [Related]
3. Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model.
Casillas-Espinosa PM; Hicks A; Jeffreys A; Snutch TP; O'Brien TJ; Powell KL
PLoS One; 2015; 10(8):e0130012. PubMed ID: 26274319
[TBL] [Abstract][Full Text] [Related]
4. The T-type calcium channel antagonist, Z944, alters social behavior in Genetic Absence Epilepsy Rats from Strasbourg.
Marks WN; Zabder NK; Cain SM; Snutch TP; Howland JG
Behav Brain Res; 2019 Apr; 361():54-64. PubMed ID: 30550952
[TBL] [Abstract][Full Text] [Related]
5. Enriched environment attenuates behavioral seizures and depression in chronic temporal lobe epilepsy.
Vrinda M; Sasidharan A; Aparna S; Srikumar BN; Kutty BM; Shankaranarayana Rao BS
Epilepsia; 2017 Jul; 58(7):1148-1158. PubMed ID: 28480502
[TBL] [Abstract][Full Text] [Related]
6. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy.
Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A
Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891
[TBL] [Abstract][Full Text] [Related]
7. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T
Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748
[TBL] [Abstract][Full Text] [Related]
8. Altered cardiac structure and function is related to seizure frequency in a rat model of chronic acquired temporal lobe epilepsy.
Powell KL; Liu Z; Curl CL; Raaijmakers AJA; Sharma P; Braine EL; Gomes FM; Sivathamboo S; Macefield VG; Casillas-Espinosa PM; Jones NC; Delbridge LM; O'Brien TJ
Neurobiol Dis; 2021 Nov; 159():105505. PubMed ID: 34520843
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and histological assessment of the effect of intermittent feeding in the pilocarpine model of temporal lobe epilepsy.
Parinejad N; Keshavarzi S; Movahedin M; Raza M
Epilepsy Res; 2009 Sep; 86(1):54-65. PubMed ID: 19505798
[TBL] [Abstract][Full Text] [Related]
10. E2730, an uncompetitive γ-aminobutyric acid transporter-1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy.
Ali I; Silva J; Casillas-Espinosa PM; Braine E; Yamakawa GR; Hudson MR; Brady RD; Major B; Thergarajan P; Haskali MB; Wright DK; Jupp B; Vivash L; Shultz SR; Mychasiuk R; Kwan P; Jones NC; Fukushima K; Sachdev P; Cheng JY; O'Brien TJ
Epilepsia; 2023 Oct; 64(10):2806-2817. PubMed ID: 37539645
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.
Sharma S; Carlson S; Gregory-Flores A; Hinojo-Perez A; Olson A; Thippeswamy T
Neurobiol Dis; 2021 Aug; 156():105410. PubMed ID: 34087381
[TBL] [Abstract][Full Text] [Related]
12. The T-type calcium channel blocker Z944 reduces conditioned fear in Genetic Absence Epilepsy Rats from Strasbourg and the non-epileptic control strain.
Marks WN; Zabder NK; Greba Q; Cain SM; Snutch TP; Howland JG
Eur J Neurosci; 2019 Sep; 50(6):3046-3059. PubMed ID: 30889299
[TBL] [Abstract][Full Text] [Related]
13. Cav3.1 T-type calcium channel modulates the epileptogenicity of hippocampal seizures in the kainic acid-induced temporal lobe epilepsy model.
Kim CH
Brain Res; 2015 Oct; 1622():204-16. PubMed ID: 26111648
[TBL] [Abstract][Full Text] [Related]
14. Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy.
Shishmanova-Doseva M; Atanasova D; Uzunova Y; Yoanidu L; Peychev L; Marinov P; Tchekalarova J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925082
[TBL] [Abstract][Full Text] [Related]
15. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
[TBL] [Abstract][Full Text] [Related]
16. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonist AMD3100 reverses the neurogenesis promoted by enriched environment and suppresses long-term seizure activity in adult rats of temporal lobe epilepsy.
Zhou Z; Liu T; Sun X; Mu X; Zhu G; Xiao T; Zhao M; Zhao C
Behav Brain Res; 2017 Mar; 322(Pt A):83-91. PubMed ID: 28104461
[TBL] [Abstract][Full Text] [Related]
18. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
Klee R; Brandt C; Töllner K; Löscher W
Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
[TBL] [Abstract][Full Text] [Related]
19. Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy.
Kebede V; Ravizza T; Balosso S; Di Sapia R; Canali L; Soldi S; Galletti S; Papazlatani C; Karas PA; Vasileiadis S; Sforzini A; Pasetto L; Bonetto V; Vezzani A; Vesci L
Brain Behav Immun; 2024 Jul; 119():363-380. PubMed ID: 38608741
[TBL] [Abstract][Full Text] [Related]
20. T-type calcium channels regulate the acquisition and recall of conditioned fear in male, Wistar rats.
Marks WN; Zabder NK; Snutch TP; Howland JG
Behav Brain Res; 2020 Sep; 393():112747. PubMed ID: 32504730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
